Y. Sasaki

Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor

M. Kizaki, T. Nakazato, Y. Ikeda, 2007, Molecular Cancer Therapeutics.

Immune‐related adverse events correlate with improved survival in patients with advanced mucosal melanoma treated with nivolumab: A single‐center retrospective study in Japan

Y. Kiyohara, Masaki Otsuka, S. Yoshikawa, 2020, The Journal of dermatology.

Characteristic Clinicopathological Features of Secondary Extramammary Paget Disease With Underlying Anorectal Adenocarcinoma: Evenly Circumferential Perianal Distribution, Fibroepithelioma of Pinkus-like Changes, and Subepidermal Mucin Deposits Without Invasive Tumor Cells

T. Sugino, Y. Kiyohara, K. Goto, 2020, The American Journal of dermatopathology.